DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Facial Fat Transfer Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific Facial Fat Transfer Market is expected to witness market growth of 11.9% CAGR during the forecast period (2019-2025).
Fat transfer, also known as autologous fat transfer or fat grafting, is mostly conducted to improve the aesthetic value of the face by minimizing smile lines or frown lines. As a result, an increase in the incidence of these conditions due to aging and pollution stimulates the demand for a facelift, thus driving the market for facial fat transfer procedures.
The popular concept of aging gracefully has raised the demand for plastic surgery treatments, including facelifts. Patients belonging to the age of 60s and 70s are also frequent visitors at plastic surgery setups for cosmetic surgery. Among all other procedures, facelifts and eyelid surgeries are the most prominent treatments. The contemporary innovative facelift technologies provide a seamless experience for older patients through ensuring less downtime and effective aesthetic results.
Plastic surgeons progressively recommend fat grafting for facial volume augmentation surgery. They base their recommendation on the benefits of facial fat transfer procedures over traditional dermal fillers. In comparison to conventional fillers, the results of facial fat transfer have a longer shelf life, have no or lesser side effects, and prove to be cost-effective in the long run.
The market in Asia-Pacific is projected to record a substantial growth rate over the forecast period due to the high success rate of facial fat transfer procedures. The visible growth in the number of hospitals and rising healthcare services are expected to support the growth of this region in the facial fat transfer market.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Facial Fat Transfer Market, by Donor Site
1.4.2 Asia Pacific Facial Fat Transfer Market, by End Use
1.4.3 Asia Pacific Facial Fat Transfer Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Facial Fat Transfer Market by Donor Site
3.1 Asia Pacific Flank Facial Fat Transfer Market by Country
3.2 Asia Pacific Thigh Facial Fat Transfer Market by Country
3.3 Asia Pacific Abdomen Facial Fat Transfer Market by Country
Chapter 4. Asia Pacific Facial Fat Transfer Market by End-Use
4.1 Asia Pacific Clinics & surgery centers Market by Country
4.2 Asia Pacific Hospitals Market by Country
Chapter 5. Asia Pacific Facial Fat Transfer Market by Country
5.1 China Facial Fat Transfer Market
5.2 Japan Facial Fat Transfer Market
5.3 India Facial Fat Transfer Market
5.4 South Korea Facial Fat Transfer Market
5.5 Singapore Facial Fat Transfer Market
5.6 Malaysia Facial Fat Transfer Market
5.7 Rest of Asia Pacific Facial Fat Transfer Market
Chapter 6. Company Profiles
6.1 Allergan PLC
6.2 Integra LifeSciences Holdings Corporation
6.3 Bausch Health Companies, Inc.
6.4 Ipsen Pharma Biotech SAS
6.5 Ranfac Corporation
6.6 Cytori Therapeutics, Inc.
6.7 Suneva Medical, Inc.
6.8 Dr. Korman Laboratories Ltd.
6.9 Scivision Biotech, Inc.
6.10 Teoxane Laboratories SA
For more information about this report visit https://www.researchandmarkets.com/r/74x9ji
